← Back to Patent Explorer
US4128612A Expired / Lapsed US ⏱️ 0.0 years remaining

Making absorbable surgical felt

Assignee: Wyeth Holdings LLC
•
Filing: 1975-11-03
•
Granted: 1978-12-05
•
Expires: 1995-11-03
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Tissue absorbable synthetic polymeric fibers, such as polyglycolic acid, are felted to form a thin mat with at least one, and preferably both, surfaces compacted by contact with a heated embossing surface such as a hot roller. Porosity is reduced but the compacted felt retains its flexibility, and conforms readily to the surface of a bleeding wound to give effective rapid hemostasis. The hemostatic felt is conveniently but not necessarily allowed to remain in place during the healing process and is absorbed by living tissue.

Inventors

  • 👤 Roy W. Roth

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-22 19:35
CPC Classifications
A; A61; A61L; A61L15/00; A61L15/16; A61L15/42; A61L15/64; A61L27/00; A61L27/50; A61L27/58; A61L2400/00; A61L2400/04

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 133 words
A method of making sterile hemostatic surgical felt, having a textured and embossed surface, consisting entirely of a living tissue absorbable polymer which comprises: spinning a living tissue absorbable polymer into fibers of 0.5 to 12 denier, cutting said fibers into segments of from about 1/4 inch to about 3 inches in length, randomly air laying said fibers into a mat having a uniform density of from about 0.5 to about 4 ounces per square yard, heating and compressing with a texture surface to emboss said mat and bind the fibers to form a felt, the heating, embossing and texturing causing a reduction in the rate of blood penetration, and improving the adhesion to bleeding surfaces, cutting to form individual felt hemostats, and, in any order, packaging in contamination resistant packages, and sterilizing.
Claim 2
Independent Claim 133 words
A method of making sterile hemostatic surgical felt, having a textured and embossed surface, consisting entirely of a living tissue absorbable polymer which comprises: spinning a living tissue absorbable polymer into fibers of 0.5 to 12 denier, cutting said fibers into segments of from about 1/4 inch to about 3 inches in length, randomly air laying said fibers into a mat having a uniform density of from about 0.5 to about 4 ounces per square yard, heating and compressing with a texture surface to emboss said mat and bind the fibers to form a felt, the heating, embossing and texturing causing a reduction in the rate of blood penetration, and improving the adhesion to bleeding surfaces, cutting to form individual felt hemostats, and, in any order, packaging in contamination resistant packages, and sterilizing.
Claim 3
Dependent Claim 23 words
The method of claim 1 in which the individual felt hemostats are packaged in moisture proof strippable packages, and sterilized by ethylene oxide.
Claim 4
Dependent Claim 38 words
The method of claim 2 in which the living tissue absorbable polymer has glycolic acid ester linkages, is melt spun, and has a greatly reduced permeability to air due to embossing and heat compressing between heated embossing rolls.
Claim 5
Independent Claim 239 words
A method of making a sterile hemostatic surgical felt, having a textured and embossed surface, consisting entirely of a living tissue absorbable polymer of glycolic acid which comprises: melt spinning a living tissue absorbable polymer of glycolic acid into fibers of 0.5 to 12 denier, cutting said fibers into segments of from about 1/4 inches to about 3 inches in length, randomly air laying said fibers into a mat having a uniform density of about 2.25 ounces per square yard, heating and compressing between heated embossing rolls, at least one of which has a textured surface to emboss said mat and bind the fibers to form a felt, having a stiffness of 1.05 to 1.83 inches, measured as one half the length of the overhang of a specimen on a flat horizontal surface which drops to an angle of 411/2° , and which before embossing is too fragile for stiffness measurement, and an air permeability of about 135 cubic feet per minute per square foot at 0.5 inches of water pressure differential, and which before embossing has an air permeability of about 360 cubic feet per minute per square foot at 0.5 inches of water pressure differential whereby the rate of penetration of blood is reduced, and the adhesion to bleeding surfaces enhanced, and which is completely absorbed when enclosed in living tissue, cutting to form individual felt hemostats, and, in any order packaging in contamination resistant packages, sterilizing.
Claim 6
Independent Claim 239 words
A method of making a sterile hemostatic surgical felt, having a textured and embossed surface, consisting entirely of a living tissue absorbable polymer of glycolic acid which comprises: melt spinning a living tissue absorbable polymer of glycolic acid into fibers of 0.5 to 12 denier, cutting said fibers into segments of from about 1/4 inches to about 3 inches in length, randomly air laying said fibers into a mat having a uniform density of about 2.25 ounces per square yard, heating and compressing between heated embossing rolls, at least one of which has a textured surface to emboss said mat and bind the fibers to form a felt, having a stiffness of 1.05 to 1.83 inches, measured as one half the length of the overhang of a specimen on a flat horizontal surface which drops to an angle of 411/2° , and which before embossing is too fragile for stiffness measurement, and an air permeability of about 135 cubic feet per minute per square foot at 0.5 inches of water pressure differential, and which before embossing has an air permeability of about 360 cubic feet per minute per square foot at 0.5 inches of water pressure differential whereby the rate of penetration of blood is reduced, and the adhesion to bleeding surfaces enhanced, and which is completely absorbed when enclosed in living tissue, cutting to form individual felt hemostats, and, in any order packaging in contamination resistant packages, sterilizing.
Claim 7
Dependent Claim 23 words
The method of claim 4 in which the individual felt hemostats are packaged in moisture proof strippable packages, and sterilized by ethylene oxide.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-12-04 1982-06-05 1982-12-05 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-12-04 1986-06-05 1986-12-05 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-12-04 1990-06-05 1990-12-05 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag